These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20882822)

  • 41. Issues in medical aesthetics.
    Martin RH
    Adv Nurse Pract; 2006 Mar; 14(3):26. PubMed ID: 16548124
    [No Abstract]   [Full Text] [Related]  

  • 42. Comment on intragastric botulinum neurotoxin A injection: from safety to warnings.
    Galassi G
    Muscle Nerve; 2011 Mar; 43(3):452-3; author reply 453-4. PubMed ID: 21321964
    [No Abstract]   [Full Text] [Related]  

  • 43. Botulinum toxin for the treatment of menopausal hot flushes: a pilot study.
    Odo ME; Odo LM; Farias RV; Primavera RA; Leão L; Cucé LC; Juliano Y
    Dermatol Surg; 2011 Nov; 37(11):1579-83. PubMed ID: 21790852
    [No Abstract]   [Full Text] [Related]  

  • 44. Scheme to register Botox clinics is criticised for "lacking teeth".
    Kmietowicz Z
    BMJ; 2010 Sep; 341():c5037. PubMed ID: 20837580
    [No Abstract]   [Full Text] [Related]  

  • 45. Ultrasound-guided botulinum toxin injections for treatment of drooling.
    Breheret R; Bizon A; Jeufroy C; Laccourreye L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):224-9. PubMed ID: 21600865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. General purposes. Some nurses are calling for a return to a generalist education, with specialisation left until post-registration.
    Duffin C; Lipley N
    Nurs Stand; 2002 May 1-7; 16(33):13. PubMed ID: 12035299
    [No Abstract]   [Full Text] [Related]  

  • 47. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial.
    Hexsel D; Brum C; do Prado DZ; Soirefmann M; Rotta FT; Dal'Forno T; Rodrigues TC
    J Am Acad Dermatol; 2012 Aug; 67(2):226-32. PubMed ID: 22041253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there a direct antimicrobial effect of botulinum neurotoxin type A?
    Wöllner J; Schmidig K; Gregorini F; Kessler TM; Zbinden R; Mehnert U
    BJU Int; 2012 Dec; 110(11 Pt C):E886-90. PubMed ID: 22882378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case 5: neighbourliness (b). Nurses using their registration status inappropriately.
    Castledine G
    Br J Nurs; 1999 May 27-Jun 9; 8(10):639. PubMed ID: 10624192
    [No Abstract]   [Full Text] [Related]  

  • 50. A case for a pre-registration branch in primary care nursing.
    Smith M
    Nurs Stand; 2003 Jun 25-Jul 1; 17(41):39-42. PubMed ID: 12861803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results.
    Kessler TM; Khan S; Panicker JN; Elneil S; Brandner S; Fowler CJ; Roosen A
    Eur Urol; 2010 May; 57(5):879-83. PubMed ID: 19765885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Practical applications of a new botulinum toxin.
    Hexsel D; Spencer JM; Woolery-Lloyd H; Gilbert E
    J Drugs Dermatol; 2010 Mar; 9(3 Suppl):s31-7. PubMed ID: 20361474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Models of initial training and pathways to registration: a selective review of policy in professional regulation.
    Fealy GM; Carney M; Drennan J; Treacy M; Burke J; O'Connell D; Howley B; Clancy A; McHugh A; Patton D; Sheerin F
    J Nurs Manag; 2009 Sep; 17(6):730-8. PubMed ID: 19694916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specialist practice: are there differences between nurses and midwives?
    Murray C
    Br J Nurs; 1996 Apr 25-May 8; 5(8):466. PubMed ID: 8788457
    [No Abstract]   [Full Text] [Related]  

  • 55. [Wrinkle fillers in cosmetic facial procedures].
    Jaspers GW; Schepers RH; Pijpe J; Jansma J
    Ned Tijdschr Tandheelkd; 2014 May; 121(5):269-74. PubMed ID: 24881255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of Botulinum Toxin Aesthetic Outcomes: Clinical Study vs Real-World Practice.
    Glogau R; Biesman B; Kane M
    JAMA Dermatol; 2015 Nov; 151(11):1177-8. PubMed ID: 26375723
    [No Abstract]   [Full Text] [Related]  

  • 57. The continuing evolution of neurotoxins for nonsurgical facial rejuvenation: an introduction.
    Matarasso A
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S29-30. PubMed ID: 19945001
    [No Abstract]   [Full Text] [Related]  

  • 58. The 1979 Nurses', Midwives' and Health Visitors' Act.
    Nurs Times; 1998 Jan 14-20; 94(2):3. PubMed ID: 9510774
    [No Abstract]   [Full Text] [Related]  

  • 59. An update on the UKCC's work into higher level practice.
    Castledine G
    Br J Nurs; 1998 Dec 10-1999 Jan 13; 7(22):1378-80. PubMed ID: 10076217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complete continence after botulinum neurotoxin type A injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks.
    Khan S; Panicker J; Roosen A; Gonzales G; Elneil S; Dasgupta P; Fowler CJ; Kessler TM
    Eur Urol; 2010 May; 57(5):891-6. PubMed ID: 19394133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.